Surgery Partners Overview
Surgery Partners Target Price
Where could SGRY trade next? Consensus target price: $19.
Get informed when a big investor buys or sells
+ FollowShare Price
$13.33
Average Target Price
$18.50
38.8% upside
38.8% upside2 analysts in the last 4 months
High: $19 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-11 | Raymond JamesSarah James | $18 | 35% upside |  |
| 2026-08-11 | RBC Capital | $19 | 42.5% upside | |
| 2026-05-06 | Jefferies | $17 | 27.5% upside | |
| 2026-04-20 | Jefferies | $15 | 12.5% upside | |
| 2026-03-11 | US Capital Advisors | $21 | 57.5% upside | |
| 2026-03-04 | JefferiesBrian Tanquilut | $16.25 | 21.9% upside | |
| 2026-03-04 | RBC CapitalBen Hendrix | $20 | 50% upside | |
| 2026-03-03 | Jefferies | $30 | 125.1% upside | |
| 2025-12-18 | Mizuho Securities | $19 | 42.5% upside | |
| 2025-11-21 | Barclays | $18 | 35% upside | |
| 2025-11-17 | Mizuho Securities | $22 | 65% upside | |
| 2024-11-13 | JefferiesBrian Tanquilut | $40 | 200.1% upside | |
| 2024-11-13 | BarclaysAndrew Mok | $31 | 132.6% upside | |
| 2024-10-14 | UBSAJ Rice | $38 | 185.1% upside | |
| 2024-06-28 | MacquarieTao Qiu | $31 | 132.6% upside | |
| 2022-05-04 | Citigroup | $64 | 380.1% upside | |